Stockscreener 앱 받기
11.79
0.59%
-0.07
전일 마감가:
$11.86
열려 있는:
$11.24
하루 거래량:
57,915
Relative Volume:
1.05
시가총액:
$22.16M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.79%
1개월 성능:
+4.06%
6개월 성능:
+104.69%
1년 성능:
+0.00%
1일 변동 폭
$10.47
$11.79
1주일 범위
$10.47
$13.28
52주 변동 폭
$2.90
$15.14
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
NEUP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
11.79 | 22.30M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
Will Neuphoria Therapeutics Inc. stock gain from government policiesQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Reversal indicators forming on Neuphoria Therapeutics Inc. stockJuly 2025 Technicals & Fast Moving Stock Watchlists - newser.com
What drives Neuphoria Therapeutics Inc stock priceFibonacci Retracement Levels & Low Entry Investment Growth - earlytimes.in
Will Neuphoria Therapeutics Inc. stock maintain momentum in 20252025 Market WrapUp & Community Trade Idea Sharing - newser.com
Can Neuphoria Therapeutics Inc. stock weather global recessionTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Measuring Neuphoria Therapeutics Inc.’s beta against major indicesJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Is Neuphoria Therapeutics Inc. stock cheap compared to fundamentalsPortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com
Is Neuphoria Therapeutics Inc a good long term investmentPrice Momentum Alerts & Identify Breakout Stocks - earlytimes.in
Neuphoria completes patient visits in phase 3 social anxiety trial By Investing.com - Investing.com Nigeria
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire
Neuphoria completes patient visits in phase 3 social anxiety trial - Investing.com India
What machine learning models say about Neuphoria Therapeutics Inc.Chart Signals & Smart Money Movement Tracker - newser.com
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire Inc.
Neuphoria Therapeutics Inc. SEC 10-K Report - TradingView
Can volume confirm reversal in Neuphoria Therapeutics Inc.Market Activity Summary & Free High Return Stock Watch Alerts - newser.com
Neuphoria Therapeutics Inc. stock volume spike explainedJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
What candlestick patterns are forming on Neuphoria Therapeutics Inc.Portfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Published on: 2025-09-29 08:17:43 - newser.com
Volume spikes in Neuphoria Therapeutics Inc. stock – what they meanJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - newser.com
What analysts say about Neuphoria Therapeutics Inc stockFlag and Pennant Patterns & Interactive Charts for Smarter Trading - earlytimes.in
Neuphoria Therapeutics Inc (NEUP) 재무 분석
Neuphoria Therapeutics Inc (NEUP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):